Literature DB >> 19684054

Safety aspects of GH replacement.

Johan Svensson1, Bengt-Ake Bengtsson.   

Abstract

In adults, GH replacement therapy will often be maintained for decades. Owing to the long duration of GH replacement in many adults, it is essential to establish the long-term safety aspects of the treatment. In this review, studies that have investigated the safety profile of long-term GH replacement will be reviewed with an emphasis on studies based on data from the Pfizer International Metabolic Database (KIMS). These studies show that long-term GH replacement in adults is safe and that long-term GH replacement may even improve cardiovascular mortality and morbidity in GH-deficient adults.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684054     DOI: 10.1530/EJE-09-0287

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  13 in total

Review 1.  The insulin-like growth factor system in cancer.

Authors:  S John Weroha; Paul Haluska
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06       Impact factor: 4.741

2.  Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(®) for the treatment of adult patients with growth hormone deficiency.

Authors:  Paolo Beck-Peccoz; Francesco Minuto; Alfonso Leal-Cerro; Markus Zabransky; Günter Stalla
Journal:  Ther Adv Endocrinol Metab       Date:  2012-06       Impact factor: 3.565

Review 3.  [Growth hormone therapy in adult patients: a review].

Authors:  Peter Herbert Kann
Journal:  Wien Klin Wochenschr       Date:  2011-05-18       Impact factor: 1.704

Review 4.  Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.

Authors:  Peter E Clayton; Indraneel Banerjee; Philip G Murray; Andrew G Renehan
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

5.  12-month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency.

Authors:  Beverly M K Biller; Hyi-Jeong Ji; Hyunji Ahn; Conrad Savoy; E Christine Siepl; Vera Popovic; Mihail Coculescu; Josefine Roemmler; Catalin Gavrila; David M Cook; Christian J Strasburger
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

6.  Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients.

Authors:  Gudmundur Johannsson; Philippe Touraine; Ulla Feldt-Rasmussen; Antonio Pico; Greisa Vila; Anders F Mattsson; Martin Carlsson; Márta Korbonits; André P van Beek; Michael P Wajnrajch; Roy Gomez; Kevin C J Yuen
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

Review 7.  Insulin-Like Growth Factor-1: A Promising Therapeutic Target for Peripheral Nerve Injury.

Authors:  Benjamin R Slavin; Karim A Sarhane; Nicholas von Guionneau; Phillip J Hanwright; Chenhu Qiu; Hai-Quan Mao; Ahmet Höke; Sami H Tuffaha
Journal:  Front Bioeng Biotechnol       Date:  2021-06-24

Review 8.  GH Replacement in the Elderly: Is It Worth It?

Authors:  Silvia Ricci Bitti; Marta Franco; Manuela Albertelli; Federico Gatto; Lara Vera; Diego Ferone; Mara Boschetti
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-15       Impact factor: 5.555

9.  Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement.

Authors:  Mary L Reed; George R Merriam; Atil Y Kargi
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-04       Impact factor: 5.555

Review 10.  Adult growth hormone deficiency: current concepts.

Authors:  Izumi Fukuda; Naomi Hizuka; Toko Muraoka; Atsuhiro Ichihara
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-07-28       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.